Rahul is a passionate doctoral researcher navigating the intricate landscape of cancer immunotherapy. Rahul's current endeavor revolves around the fascinating realm of identifying novel gene targets that hold the key to unraveling the complexities of cell resistance to complement-dependent cytotoxicity in cancer. Keywords: Complement Research, CDC, Mortalin-associated targets, C3, C9, Cd45, CD55 and CD59.